The usage of LW6 in the colon cancer cells has been shown to promote the degradation of HIF‐1α by upregulation of VHL without affecting HIF‐1β expression, giving rise to competent anti‐tumor efficacy in vivo.77 This evidence concerns the gene HIF1A and neoplasm.